Norge -
norsk -
Statens legemiddelverk
imacillin 50 mg/ ml
teva b.v. - amoksicillintrihydrat - granulat til mikstur, suspensjon - 50 mg/ ml
Norge -
norsk -
Statens legemiddelverk
imacillin 100 mg/ ml
teva b.v. - amoksicillintrihydrat - granulat til mikstur, suspensjon - 100 mg/ ml
Norge -
norsk -
Statens legemiddelverk
marcain 2.5 mg/ ml
aspen pharma trading limited - bupivakainhydroklorid - injeksjonsvæske, oppløsning - 2.5 mg/ ml
Norge -
norsk -
Statens legemiddelverk
marcain 5 mg/ ml
aspen pharma trading limited - bupivakainhydroklorid - injeksjonsvæske, oppløsning - 5 mg/ ml
Norge -
norsk -
Statens legemiddelverk
rupafin 1 mg/ ml
j. uriach & cia., sa - rupatadinfumarat - mikstur, oppløsning - 1 mg/ ml
Norge -
norsk -
Statens legemiddelverk
xylocain 20 mg/ ml
aspen pharma trading limited - lidokainhydroklorid - injeksjonsvæske, oppløsning - 20 mg/ ml
Norge -
norsk -
Statens legemiddelverk
xylocain 10 mg/ ml
aspen pharma trading limited - lidokainhydroklorid - injeksjonsvæske, oppløsning - 10 mg/ ml
Norge -
norsk -
Statens legemiddelverk
xylocain adrenalin 10 mg/ ml / 5 mikrog/ ml
aspen pharma trading limited - lidokainhydroklorid / adrenalintartrat - injeksjonsvæske, oppløsning - 10 mg/ ml / 5 mikrog/ ml
Den europeiske union -
norsk -
EMA (European Medicines Agency)
spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaksiner - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.
Norge -
norsk -
Statens legemiddelverk
apocillin 330 mg
actavis group ptc ehf (1) - fenoksymetylpenicillinkalium - tablett, filmdrasjert - 330 mg